Editor,

Soft-tissue sarcomas are rare malignancies of mesodermal origin and constitute \<1% of new malignancies. There are multiple histological sub-types and only about 10% of all sarcomas are synovial. They usually present as a painless limb mass. Metastases can be as common as 40% with high-grade tumours and occur most commonly in the lung, but may also affect liver, brain and bone [@b1].

A 27 year old man presenting with left sided chest pain was found to have multiple soft tissue lung lesions on chest x-ray ([Figure 1](#f01){ref-type="fig"}). A CT guided biopsy was unsuccessful and referral for VATS (video assisted thoracoscopic surgery) was made to obtain tissue samples.

![Chest X-ray showing multiple lung nodules](umj-86-03-204-g001){#f01}

At review 1 month after the initial chest X-ray, the presence of long-standing inflammation of the right foot became evident. The right foot had been inflamed for 6 months and was significantly larger than the left with mild erythema ([Figure 2](#f02){ref-type="fig"}). MRI of the foot revealed a large lesion at the medial aspect with bony erosion consistent with a malignant tumour.

![Swollen right foot as compared to left foot, initially thought to be unrelated](umj-86-03-204-g002){#f02}

VATS identified large abnormal lung nodules ([Figure 3](#f03){ref-type="fig"}) confirmed to be malignant on frozen section. The histology was not typical of lung carcinoma, melanoma or common pleural/lung lesions. Immunohistochemistry showed positive staining of biphasic spindle cells with CD99, EMA and bcl-2, as well as focal staining with Cam 5.2 and AE1/3 in the epithelioid areas. This favoured a diagnosis of synovial sarcoma confirmed with the presence of t(X;18) translocation identified by molecular studies. No further biopsy of the primary lesion was deemed necessary to confirm the diagnosis of metastatic synovial sarcoma.

![Macroscopic images of lung nodules during VATS procedure](umj-86-03-204-g003){#f03}

The t(X;18) chromosomal translocation identified in the sample sent for molecular pathology is typical for synovial sarcoma and essentially describes a fusion between SSX on chromosome X and SS18 on chromosome 18[@b2]^,^[@b3]. This translocation is virtually pathognomonic for human synovial sarcoma [@b3]. The fusion process is similar to the oncogenesis of certain leukaemias [@b2].

The stable SS18-SSX fusion protein created as a result of the translocation is subsequently incorporated into the BAF complex. This prevents the BAF47 subunit, usually part of the complex, from inclusion. BAF47 is a tumour suppressor gene and its absence may play a significant role in the development of synovial sarcoma[@b2]. Interestingly, proliferation of synovial sarcoma may be potentially reversible if normal complexes are reassembled. This may guide the development of future therapeutic agents[@b3].

This case highlights the importance of a thorough patient review. This was an atypical presentation of synovial sarcoma with the pulmonary metastases identified prior to the primary malignancy. It is unusual for synovial sarcoma to be identified from incidental findings of lung metastases. The patient was treated with trabectadin instead of doxorubicin in view of compromised left ventricular ejection fraction. Trabectadin is at least as efficacious as doxorubicin for the treatment of translocation-related sarcomas[@b4]. One year after initial diagnosis he is receiving palliative chemotherapy, with metastases mostly stable in size. The mass in the right foot has continued to grow in size, as have some of the pulmonary nodules.
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